FI873566L - Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem. - Google Patents

Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem. Download PDF

Info

Publication number
FI873566L
FI873566L FI873566A FI873566A FI873566L FI 873566 L FI873566 L FI 873566L FI 873566 A FI873566 A FI 873566A FI 873566 A FI873566 A FI 873566A FI 873566 L FI873566 L FI 873566L
Authority
FI
Finland
Prior art keywords
huden
farmaceutiska
absorberas
preparat
genom
Prior art date
Application number
FI873566A
Other languages
English (en)
Finnish (fi)
Other versions
FI873566A0 (fi
FI873566A7 (fi
Inventor
Masato Azuma
Toshihiro Inoue
Yasuaki Kawano
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI873566A0 publication Critical patent/FI873566A0/fi
Publication of FI873566A7 publication Critical patent/FI873566A7/fi
Publication of FI873566L publication Critical patent/FI873566L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI873566A 1986-08-18 1987-08-18 Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem. FI873566L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19249386 1986-08-18
JP19249286 1986-08-18
JP8027687 1987-04-01

Publications (3)

Publication Number Publication Date
FI873566A0 FI873566A0 (fi) 1987-08-18
FI873566A7 FI873566A7 (fi) 1988-02-19
FI873566L true FI873566L (fi) 1988-02-19

Family

ID=27303257

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873566A FI873566L (fi) 1986-08-18 1987-08-18 Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem.

Country Status (18)

Country Link
US (1) US5211943A (cs)
EP (1) EP0260452B1 (cs)
KR (1) KR880002523A (cs)
CN (1) CN87105632A (cs)
AR (2) AR241513A1 (cs)
AT (1) ATA207887A (cs)
AU (1) AU7717587A (cs)
BE (1) BE1000477A3 (cs)
CS (1) CS601987A2 (cs)
DE (1) DE3782594T2 (cs)
DK (1) DK424987A (cs)
ES (1) ES2052528T3 (cs)
FI (1) FI873566L (cs)
GR (1) GR871267B (cs)
HU (1) HU200923B (cs)
NO (1) NO873423L (cs)
NZ (1) NZ221465A (cs)
PT (1) PT85543B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2886446B2 (ja) * 1994-03-03 1999-04-26 関西ペイント株式会社 塗膜保護用シート
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
KR100674108B1 (ko) * 1999-04-13 2007-01-26 히사미쓰 세이야꾸 가부시키가이샤 경피흡수형 제제
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
EP4370121A1 (en) 2021-07-10 2024-05-22 Auxilius Pharma Spolka Z Ograniczona Odpowiedzialnoscia Modified release nicorandil compound formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS5910513A (ja) * 1982-07-12 1984-01-20 Nitto Electric Ind Co Ltd 医薬製剤
JPS60184010A (ja) * 1984-03-02 1985-09-19 Nitto Electric Ind Co Ltd 経皮投与用医薬製剤
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
JPH0627068B2 (ja) * 1984-09-22 1994-04-13 中外製薬株式会社 経皮薬剤
JPS61103840A (ja) * 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device

Also Published As

Publication number Publication date
US5211943A (en) 1993-05-18
CS601987A2 (en) 1990-08-14
AR240017A1 (es) 1990-01-31
DE3782594T2 (de) 1993-06-03
NZ221465A (en) 1989-12-21
ATA207887A (de) 1990-08-15
DE3782594D1 (de) 1992-12-17
EP0260452A1 (en) 1988-03-23
GR871267B (en) 1987-12-24
FI873566A0 (fi) 1987-08-18
AU7717587A (en) 1988-02-25
AR241513A1 (es) 1992-08-31
FI873566A7 (fi) 1988-02-19
DK424987D0 (da) 1987-08-14
BE1000477A3 (fr) 1988-12-20
KR880002523A (ko) 1988-05-09
PT85543A (en) 1987-09-01
HU200923B (en) 1990-09-28
NO873423L (no) 1988-02-19
HUT45397A (en) 1988-07-28
NO873423D0 (no) 1987-08-14
ES2052528T3 (es) 1994-07-16
PT85543B (en) 1989-11-06
EP0260452B1 (en) 1992-11-11
CN87105632A (zh) 1988-03-30
DK424987A (da) 1988-02-19

Similar Documents

Publication Publication Date Title
FI870104L (fi) Negativa, fotoelektriskt resistenta kompositioner och foerfaranden foer framstaellning av vaermestabila negativbilder genom att anvaenda dem.
FI875220L (fi) Mikrober foerhaerjande proteiner, sammansaettningar som innehaoller dem och deras anvaendning.
FI864949L (fi) Fluorerade akrylmonomerer, polymerer haerledda daerav och anvaendning av dessa som hydrofoba och oleofoba aemnen.
FI872106A0 (fi) Extrakt av nerium-arter, foerfarande foer framstaellning av dem och deras anvaendning.
FI885052L (fi) Katalysatorsystem, som foerhindrar bildning av svavelvaete och som innehaoller kopparoxid.
FI870010L (fi) Foerfarande foer framnstaellning av genom fotopolymerisation tvaerbundna reliefformar.
FI891227L (fi) Katekolderivat och farmaceutiska preparat som innehaoller dessa.
FI891222A7 (fi) Arylpiperazinylalkoxiderivat av cykliska imider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI860430A0 (fi) Foerfarande och anordning foer utnyttjande av vaermeenergi som frigoers i kylprocess.
FI921562L (fi) Gem-difosfonsyror, foerfarande foer framstaellning av dessa och farmaceutiska sammansaettningar som inne- haoller dem.
FI872905L (fi) Fuktvatten och tryckeriprocesser som anvaender dem.
FI864164L (fi) Biologiskt aktiva derivat av human- -interferon, deras framstaellning och laekemedel, som innehaoller dylika derivat.
FI871270A7 (fi) L-dopa-derivat, foerfarande foer framstaellning av dem och farmaceutiska sammansaettningar som innehaoller dem.
FI863626L (fi) Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin.
FI875359L (fi) Vaermehaerdbara sammansaettningar anvaendbara som b-steg, foerfarande foer deras framstaellning och anvaendning av dessa sammansaettningar.
FI870585L (fi) Purinderivat, deras framstaellning och medikament som innehaoller dem.
FI873501A0 (fi) Heteroaryletylaminer, foerfarande foer framstaellning av dem och deras anvaendning som produktionsbefraemjande medel foer djur.
FI873566L (fi) Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem.
FI862386L (fi) Foerfarande foer framstaellning av alkyl- eller aralkyltio-2-cykloalken-1-karboxamider-1 och deras sulfoxider och foer anvaendning av dem som mellanprodukter vid syntes av tri- och tetrametylen-4,5-isotiazolin-4-oner-3.
FI865347L (fi) Gonadoliberinderivat som innehaoller en aromatisk aminokarbozylsyra i position 6, farmaceutiska och veterinaera preparat innehaollande dessa och foerfarande foer framstaellning daerav.
FI843246L (fi) Hydrocortison-17-oxo-21-tioestrar, framstaellning av dem och anvaendning av dem som laekemedel.
FI873852L (fi) Foereningar av 2,3,4,5,6,7-hexahydro-2,7 -metanol-1,5-benzoxazonin, foerfarande foer deras framstaellning och laekemedel, som innehaoller dessa foereningar.
FI875540L (fi) Polymerer innehaollande imidgrupper, framstaellda av steriskt foerhindrade diaminer, och foerfaranden foer framstaellning av dem.
FI73529B (fi) Foerfarande foer utfoerande av vaetskeanalys och analyselement som anvaends i foerfarandet.
FI843208A7 (fi) 7 -substituerade 3-oxo-17 -pregn-4-en -21,17-karbolaktoner, foerfaranden foer framstaellning av dem och farmaceutiska preparat innehaollande dem.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: CHUGAI SEIYAKU KABUSHIKI KAISHA